deltorphin ii, ala(2)- has been researched along with 4-carboxyphenylglycine in 1 studies
| Studies (deltorphin ii, ala(2)-) | Trials (deltorphin ii, ala(2)-) | Recent Studies (post-2010) (deltorphin ii, ala(2)-) | Studies (4-carboxyphenylglycine) | Trials (4-carboxyphenylglycine) | Recent Studies (post-2010) (4-carboxyphenylglycine) |
|---|---|---|---|---|---|
| 233 | 0 | 20 | 54 | 0 | 9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, T; Nagase, H; Narita, M; Ohnishi, O; Suzuki, T | 1 |
1 other study(ies) available for deltorphin ii, ala(2)- and 4-carboxyphenylglycine
| Article | Year |
|---|---|
Different effects of NMDA/group I metabotropic glutamate receptor agents in delta- and mu-opioid receptor agonist-induced supraspinal antinociception.
Topics: Analgesics; Animals; Benzoates; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Excitatory Amino Acid Antagonists; Glycine; Injections, Intraventricular; Male; Mice; Oligopeptides; Pain Measurement; Quinolines; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, delta; Receptors, Opioid, mu | 2000 |